The Mouthwash Listerine May Help Treat Gonorrhea

Listerine was first invented in the late 19th century, and as early at 1879, manufacturers claimed the disinfectant was effective at both cleaning floors and curing gonorrhea. Now, 137 years later, scientists have published the first ever randomized controlled trial testing Listerine’s gonorrhea claim in the medical journal Sexually Transmitted Infections. The verdict: the bad-breath mouthwash does indeed kill gonorrhea bacteria, both in petri dishes and in people’s throats. Gonorrhea is a mild, sometimes asymptomatic bacterial infection that can cause infertility, sterility and even death if left untreated. And if further trials show that Listerine’s immediate effectiveness against gonorrhea translates into a long-term preventive tool, then public health officials and people at high risk of this STI have a cheap, easy way to prevent the disease, said the researchers. Scientists led by lead study author Eric Chow, a research fellow at the Melbourne Sexual Health Centre in Australia, first tested various concentrations of Listerine to see if it was effective at reducing bacterial counts of gonorrhea in a petri dish compared to saline solution. They found that Listerine dilutions of up to one in four resulted in significant growth inhibition of gonorrhea when exposed for one minute, while saline solution prompted no change. In the second study, a randomized controlled trial, Chow’s team recruited 58 gay or bisexual men who tested positive for gonorr...
Source: Science - The Huffington Post - Category: Science Source Type: news

Related Links:

In an open-label clinical trial, Jabbari and colleagues demonstrated clinical efficacy of the small molecule JAK1,3 inhibitor tofacitinib in 12 patients with moderate-to-severe alopecia areata (AA), a disease that results from autoimmune attack on the hair follicles with resulting significant hair loss. Tofacitinib, which has previously been approved for treatment of rheumatoid arthritis, halted hair loss and allowed considerable regrowth in 11 of these patients without serious adverse effects. Although the therapy is non-curative, as evidenced by relapse after treatment cessation, tofacitinib is a promising therapy for th...
Source: Journal of Investigative Dermatology - Category: Dermatology Tags: Editorial Source Type: research
CONCLUSION: Ceftriaxone is still suitable as a component of gonorrhoea treatment in our region but resistance to other agents prohibits their use for empiric treatment regimens. Current methods of detecting antimicrobial resistance for NG needed to be updated so that they are fit for purpose. PMID: 29927918 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
[Bhekisisa] HIV is a mirror that reflects how we think about society. It exposes our prejudices. Find out how to tell interesting stories about it.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
Multimillion pound grants have been awarded to four UK universities to conduct research into AMR in low and middle income countries, as part of thecross-research council AMR initiative and theNIHR’s Global Health Research Programme.
Source: Medical Research Council General News - Category: Research Source Type: news
Learn about the use of Janus kinase inhibitors, which have become promising treatment options for dermatologic conditions such as psoriasis, atopic dermatitis, alopecia areata, vilitigo, and more.Skin Therapy Letter
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Conclusion: A high level of SCCmec genetic diversity was found among MR-CoNS isolates. MR-CoNS may act as a reservoir of SCCmec IV for MRSA. This issue should be taken into consideration seriously. PMID: 29922413 [PubMed]
Source: Iranian Journal of Microbiology - Category: Microbiology Tags: Iran J Microbiol Source Type: research
(Natural News) Polycystic Ovarian Syndrome (PCOS) is the most common endocrine disorder in women and the most common cause of female infertility. This condition occurs when the ovaries produce more androgens (male sex hormones) than normal. Too much androgens may lead to a number of symptoms, including those related to diabetes. In addition, cysts tend to...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
AbstractPurpose of ReviewThis review describes current guidelines and research on screening, diagnostics, and treatment for sexually transmitted infections (STIs) seen in the emergency department (ED).Recent FindingsMany studies support less invasive testing for STIs, which in turn would encourage increased screening. The diagnosis of pelvic inflammatory disease (PID) is currently based on clinical findings and further research is needed to improve diagnostic accuracy. Current antibiotic treatment guidelines are based on numerous studies. Drug-resistant gonorrhea is an issue worldwide and alternative treatments are current...
Source: Current Emergency and Hospital Medicine Reports - Category: Emergency Medicine Source Type: research
Conclusions This meta-analysis provides an update and stronger evidence to support the observation that BT is associated with a higher proportion of males and an increased risk of MZT. In clinical practice, these BT-associated neonatal outcomes should be taken into account when counselling infertility patients.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research
Australasian Journal of Dermatology, EarlyView.
Source: Australasian Journal of Dermatology - Category: Dermatology Authors: Source Type: research
More News: Alopecia | Centers for Disease Control and Prevention (CDC) | Gonorrhoea | Infertility | International Medicine & Public Health | Reproduction Medicine | Science | STDs | Study | Superbugs | Websites | Women